Xtant Medical Holdings (XTNT) Accumulated Depreciation & Amortization (2016 - 2025)
Xtant Medical Holdings (XTNT) has disclosed Accumulated Depreciation & Amortization for 15 consecutive years, with $21.9 million as the latest value for Q3 2025.
- Quarterly Accumulated Depreciation & Amortization rose 4.13% to $21.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $21.9 million through Sep 2025, up 4.13% year-over-year, with the annual reading at $4.2 million for FY2024, 78.54% down from the prior year.
- Accumulated Depreciation & Amortization for Q3 2025 was $21.9 million at Xtant Medical Holdings, up from $21.2 million in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $21.9 million in Q3 2025, with the low at $4.2 million in Q4 2024.
- Average Accumulated Depreciation & Amortization over 5 years is $18.2 million, with a median of $18.2 million recorded in 2023.
- Peak annual rise in Accumulated Depreciation & Amortization hit 12.56% in 2024, while the deepest fall reached 78.54% in 2024.
- Over 5 years, Accumulated Depreciation & Amortization stood at $17.2 million in 2021, then increased by 4.63% to $18.0 million in 2022, then increased by 9.55% to $19.7 million in 2023, then tumbled by 78.54% to $4.2 million in 2024, then soared by 417.52% to $21.9 million in 2025.
- According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $21.9 million, $21.2 million, and $20.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.